Sulfonylurea

Does medication type make a difference?… 

Approximately two-fold increase…. 

Post market study results…. 

Tolerability in type 2 diabetes patients aged 65 years and older…. 

Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor PEDIATRICS – Jane Lee Chiang, MD, and Georgeanna J. Klingensmith, MD ADULTS – Irl B. Hirsch, MD 1. Basal insulin accounts for ~50% of total daily dose: i. LAA (insulin glargine, detemir, degludec) or NPH if LAA …

Can basal insulin can make a difference?… 

Minimizing hypoglycemia in type 2 diabetes patients…. Hypoglycemia is a common problem among patients taking combinations of insulin and sulfonylureas and may be a limiting factor in diabetes therapy management. Hypoglycemia is defined by the American Diabetes Association (ADA) as a plasma glucose of 79mg/dL. (3.9mmol/L) or less; however most people …

New research assesses safety and efficacy of linagliptin as add on treatment in elderly diabetes patients….

Does Bydureon once weekly show benefit in type 2 diabetic patients?…

Scientific understanding of the disease shifts treatment to drugs with newer mechanisms….